Despite being one of the game’s most anticipated features, development on Cities Skylines 2’s assets editor has taken a backseat for now.

is at the forefront of RNA editing technology, with its lead candidate KRRO-110 poised to potentially revolutionize the treatment of Alpha-1 Antitrypsin Deficiency (AATD). Trading at $13.80, ...

The Academy produces a series of guides for middle and high school teachers to facilitate the classroom exploration of the art and science of motion pictures. The activities are designed to tap ...